MedTrace Logo

Effect of Cross Frequency tACS on Cognitive Control

NCT03800030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2020-05-18

Study results available
· View outcomes & findings →

Summary

Investigation of frequency specific transcranial alternating current stimulation on cognitive control signals in frontal cortex

Conditions

  • Cognitive Control
  • Executive Function

Interventions

DEVICE

Theta-gamma tACS

NeuroConn technologies, direct current-stimulator plus

DEVICE

Delta-beta tACS

NeuroConn technologies, direct current-stimulator plus

DEVICE

Sham tACS

NeuroConn technologies, direct current-stimulator plus

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Flavio Frohlich, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-07
Primary Completion
2019-07-25
Completion
2019-07-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03800030 on ClinicalTrials.gov